Supplemental Material: Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.

Articles in this issue

---

Use of COTA Nodal Address Highlights Variance in Cancer Care Cost: An Interview With Donald M. Berwick, MD, MPP

Radiation Oncology’s Role in the Next Chapter of Payment Reform

ACCC and ASCO Collaborative Targets Disparities in Cancer Clinical Trials

Flying the Plane While You Build It

The Untapped Potential of Cell and Gene Therapy

Interview: Tanya Siddiqi, MD, Discusses the Promise of Reduced Toxicity With Liso-Cel

FDA Approves Osimertinib for Adjuvant Treatment of Early-Stage EGFR-Mutated NSCLC

Certain NSCLC Patients Are More Likely to Respond to Immunotherapy, Study Results Show

Possible Treatment Identified for Aggressive NSCLC Subset

Contributor: A Practical Path Forward to More Patient-Centered Value Assessment

Proximity to Treatment, Racial Disparities Are Seen in Ovarian Cancer Survival

Lung Cancer Screenings Fall, Biopsy Rates Rise During COVID-19

As Mammography Screenings Drop, Advanced Breast Cancer Cases Increase in First Months of COVID-19

Azacitidine Is Shown to Improve Overall, Relapse-Free Survival in Older Adults With AML

FDA Updates Ibrutinib Label With 5-Year Data in Waldenström Macroglobulinemia

Related Videos

Related Content

Advertisement

October 2nd 2024

Implementation of Two Guideline-Based Pilot Programs for Patients With ASCVD: Strategies and Perspectives

March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.

September 19th 2024

Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries

Mariétou H. Ouayogodé, PhD Brianna Hardy, BS John Mullahy, PhD Maureen A. Smith, MD, PhD, MPH Ellen Meara, PhD

Hospital care transition activity facilitates uptake of Medicare-reimbursed transitional care management, which is associated with lower spending and better patient outcomes.

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Maggie L. Shaw

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

September 18th 2024

It’s Time to Address Our Nation’s Health Care Price Crisis

Guy D’Andrea, MBA Torie Nugent-Peterson

This commentary introduces Catalyst for Payment Reform’s and the Employers’ Forum of Indiana’s new campaign, Price Crisis, which will mobilize individuals, employers, and policy makers with evidence, guidance, and resources to take meaningful actions.

September 17th 2024

Part B Losses to Oncologists Due to IRA Could Total $12B Through 2032 Across Medicare, Commercial Plans

Mary Caffrey

Based on an Avalere Health report, Community Oncology Alliance warns that IRA negotiations could slice down payments needed to administer cancer drugs.

Related Content

Advertisement

October 2nd 2024

Implementation of Two Guideline-Based Pilot Programs for Patients With ASCVD: Strategies and Perspectives

March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.

September 19th 2024

Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries

Mariétou H. Ouayogodé, PhD Brianna Hardy, BS John Mullahy, PhD Maureen A. Smith, MD, PhD, MPH Ellen Meara, PhD

Hospital care transition activity facilitates uptake of Medicare-reimbursed transitional care management, which is associated with lower spending and better patient outcomes.

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Maggie L. Shaw

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

September 18th 2024

It’s Time to Address Our Nation’s Health Care Price Crisis

Guy D’Andrea, MBA Torie Nugent-Peterson

This commentary introduces Catalyst for Payment Reform’s and the Employers’ Forum of Indiana’s new campaign, Price Crisis, which will mobilize individuals, employers, and policy makers with evidence, guidance, and resources to take meaningful actions.

September 17th 2024

Part B Losses to Oncologists Due to IRA Could Total $12B Through 2032 Across Medicare, Commercial Plans

Mary Caffrey

Based on an Avalere Health report, Community Oncology Alliance warns that IRA negotiations could slice down payments needed to administer cancer drugs.